[1] 陈凤,冷玉芳,任以行,等. 表观遗传调控在阻塞性睡眠呼吸暂停综合征中的作用研究进展[J]. 基础医学与临床,2021,41:899-903. [2] Mohamed B, Yarlagadda K, Self Z, et al. Obstructive sleep apnea and stroke: determining the mechanisms behind their association and treatment options[J]. Transl Stroke Res, 2024, 15: 239-332. [3] 陈丽萍,史永兴,陈艳红,等. 血清MC-CP、CCL26、DcR3水平在COPD并发OSAS诊断中的临床价值[J]. 基础医学与临床,2025,45:76-80. [4] 金萍萍,杨琼,李小刚. 阻塞性睡眠呼吸暂停综合征与缺血性脑卒中相关性研究现状与展望[J]. 中华老年心脑血管病杂志,2022,24:894-896. [5] Kurra N, Gandrakota N, Ramakrishnan M, et al. The influence of obstructive sleep apnea on post-stroke complications: a systematic review and Meta-analysis[J]. J Clin Med, 2024, 13: 5646.doi:10.3390/jcm13185646. [6] Baillieul S, Dekkers M, Brill AK, et al. Sleep apnoea and ischaemic stroke: current knowledge and future directions[J]. Lancet Neurol, 2022, 21: 78-88. [7] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国脑出血诊治指南(2019)[J]. 中华神经科杂志,2019,52:994-1005. [8] Schirò G, Iacono S, Ragonese P, et al. A brief overview on BDNF-Trk pathway in the nervous system: a potential biomarker or possible target in treatment of multiple sclerosis?[J] Front Neurol, 2022,13:917527.doi:10.3389/fneur.2022.917527. [9] Hale E, Gottlieb E, Usseglio J, et al. Post-stroke sleep disturbance and recurrent cardiovascular and cerebrovascular events: a systematic review and Meta-analysis[J]. Sleep Med, 2023, 104: 29-41. [10] Gleeson M, McNicholas WT. Bidirectional relationships of comorbidity with obstructive sleep apnoea[J]. Eur Respir Rev, 2022, 31: 210256.doi:10.1183/16000617.0256-2021. [11] Rajamanickam G, Lee ATH, Liao P, et al. Role of brain derived neurotrophic factor and related therapeutic strategies in central post-stroke pain[J]. Neurochem Res, 2024, 49: 2303-2318. [12] Brunelli S, Giannella E, Bizzaglia M, et al. Secondary neurodegeneration following stroke: What can blood biomarkers tell us?[J]. Front Neurol, 2023, 14: 1198216.doi:10.3389/fneur.2023.1198216. |